TASK3

1

Lan X et al. Grafting voltage and pharmacological sensitivity in potassium channels.
Cell Res., 2016 May 13 , ().

2

Skarsfeldt MA et al. pH-dependent inhibition of K2P3.1 prolongs atrial refractoriness in whole hearts.
Pflugers Arch., 2016 Jan 5 , ().

3

Laskowski M et al. What do we not know about mitochondrial potassium channels?
Biochim. Biophys. Acta, 2016 Aug , 1857 (1247-57).

4

Sun H et al. A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis.
Nat Commun, 2016 , 7 (10339).

5

Chokshi RH et al. Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.
Mol. Pharmacol., 2015 Nov , 88 (926-34).

6

Li XJ et al. [Neuroprotective effect of progesterone on focal cerebral ischemia/reperfusion injury in rats and its mechanism].
Zhongguo Ying Yong Sheng Li Xue Za Zhi, 2015 May , 31 (231-4).

7

Wei LY et al. [Construction of acid-sensitive potassium channel-3 eukaryotic expression plasmid and its express in SH-SY5Y cells].
Zhongguo Ying Yong Sheng Li Xue Za Zhi, 2015 May , 31 (211-5).

8

Kilisch M et al. The role of protein-protein interactions in the intracellular traffic of the potassium channels TASK-1 and TASK-3.
Pflugers Arch., 2015 May , 467 (1105-20).

9

MacKenzie G et al. Two-pore domain potassium channels enable action potential generation in the absence of voltage-gated potassium channels.
Pflugers Arch., 2015 May , 467 (989-99).

10

Mathie A et al. Two-pore domain potassium channels: potential therapeutic targets for the treatment of pain.
Pflugers Arch., 2015 May , 467 (931-43).

11

Bayliss DA et al. The role of pH-sensitive TASK channels in central respiratory chemoreception.
Pflugers Arch., 2015 May , 467 (917-29).

12

Bandulik S et al. Two-pore domain potassium channels in the adrenal cortex.
Pflugers Arch., 2015 May , 467 (1027-42).

13

Langford DJ et al. Variations in potassium channel genes are associated with distinct trajectories of persistent breast pain after breast cancer surgery.
Pain, 2015 Mar , 156 (371-80).

14

Borsotto M et al. Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.
Br. J. Pharmacol., 2015 Feb , 172 (771-84).

15

Ru F et al. Acid sensitivity of the spinal dorsal root ganglia C-fiber nociceptors innervating the guinea pig esophagus.
Neurogastroenterol. Motil., 2015 Apr 5 , ().

16

Kubota K et al. Hydroxy-α sanshool induces colonic motor activity in rat proximal colon: a possible involvement of KCNK9.
Am. J. Physiol. Gastrointest. Liver Physiol., 2015 Apr 1 , 308 (G579-90).

17

Braun G et al. Differential sensitivity of TREK-1, TREK-2 and TRAAK background potassium channels to the polycationic dye ruthenium red.
Br. J. Pharmacol., 2015 Apr , 172 (1728-38).

18

Rinné S et al. TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes.
J. Mol. Cell. Cardiol., 2015 Apr , 81 (71-80).

19

Morenilla-Palao C et al. Ion channel profile of TRPM8 cold receptors reveals a role of TASK-3 potassium channels in thermosensation.
Cell Rep, 2014 Sep 11 , 8 (1571-82).

20

Sánchez Delgado M et al. Screening individuals with intellectual disability, autism and Tourette's syndrome for KCNK9 mutations and aberrant DNA methylation within the 8q24 imprinted cluster.
Am. J. Med. Genet. B Neuropsychiatr. Genet., 2014 Sep , 165B (472-8).

21

Perry JR et al. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.
Nature, 2014 Oct 2 , 514 (92-7).

22

Veale EL et al. Recovery of current through mutated TASK3 potassium channels underlying Birk Barel syndrome.
Mol. Pharmacol., 2014 Mar , 85 (397-407).

23

Li C et al. Stable cell line of human SH-SY5Y uniformly expressing TWIK-related acid-sensitive potassium channel and eGFP fusion.
Appl. Biochem. Biotechnol., 2014 Mar , 172 (3253-62).

24

Bruner JK et al. Identification of novel small molecule modulators of K2P18.1 two-pore potassium channel.
Eur. J. Pharmacol., 2014 Jun 24 , ().

25

Hoggart CJ et al. Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index.
PLoS Genet., 2014 Jul , 10 (e1004508).

26

Langford DJ et al. Variations in Potassium Channel Genes Are Associated With Breast Pain in Women Prior to Breast Cancer Surgery.
J. Neurogenet., 2014 Jan 7 , ().

27

El Hachmane MF et al. Enhancement of TWIK-related Acid-sensitive Potassium Channel 3 (TASK3) Two-pore Domain Potassium Channel Activity by Tumor Necrosis Factor α.
J. Biol. Chem., 2014 Jan 17 , 289 (1388-401).

28

Gomez-Sanchez CE et al. Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy?
Endocrinology, 2014 Jan , 155 (47-55).

29

Marinc C et al. Immunocytochemical localization of TASK-3 protein (K2P9.1) in the rat brain.
Cell. Mol. Neurobiol., 2014 Jan , 34 (61-70).

30

Nagy D et al. Silencing the KCNK9 potassium channel (TASK-3) gene disturbs mitochondrial function, causes mitochondrial depolarization, and induces apoptosis of human melanoma cells.
Arch. Dermatol. Res., 2014 Dec , 306 (885-902).

31

Flaherty DP et al. Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffold.
Bioorg. Med. Chem. Lett., 2014 Aug 15 , 24 (3968-73).

32

Noriega-Navarro R et al. Novel TASK channels inhibitors derived from dihydropyrrolo[2,1-a]isoquinoline.
Neuropharmacology, 2014 Apr , 79 (28-36).

33

Wilke BU et al. Diacylglycerol mediates regulation of TASK potassium channels by Gq-coupled receptors.
Nat Commun, 2014 , 5 (5540).

34

Mant A et al. Acid sensitive background potassium channels K2P3.1 and K2P9.1 undergo rapid dynamin-dependent endocytosis.
Channels (Austin), 2013 Jul-Aug , 7 (288-302).

35

Toczyłowska-Mamińska R et al. Potassium Channel in the Mitochondria of Human Keratinocytes.
J. Invest. Dermatol., 2013 Oct 14 , ().

36

Pollema-Mays SL et al. Expression of background potassium channels in rat DRG is cell-specific and down-regulated in a neuropathic pain model.
Mol. Cell. Neurosci., 2013 Nov , 57 (1-9).

37

Stowasser M Primary aldosteronism and potassium channel mutations.
Curr Opin Endocrinol Diabetes Obes, 2013 Jun , 20 (170-9).

38

Matsuoka H et al. Nerve growth factor-induced endocytosis of TWIK-related acid-sensitive K⁺ 1 channels in adrenal medullary cells and PC12 cells.
Pflugers Arch., 2013 Jul , 465 (1051-64).

39

Turner PJ et al. Oxygen and mitochondrial inhibitors modulate both monomeric and heteromeric TASK-1 and TASK-3 channels in mouse carotid body type-1 cells.
J. Physiol. (Lond.), 2013 Dec 1 , 591 (5977-98).

40

Bandulik S et al. Severe hyperaldosteronism in neonatal Task3 potassium channel knockout mice is associated with activation of the intraadrenal renin-angiotensin system.
Endocrinology, 2013 Aug , 154 (2712-22).

41

Anders C et al. A semisynthetic fusicoccane stabilizes a protein-protein interaction and enhances the expression of K+ channels at the cell surface.
Chem. Biol., 2013 Apr 18 , 20 (583-93).

42

Nadin BM et al. A new TASK for Dipeptidyl Peptidase-like Protein 6.
PLoS ONE, 2013 , 8 (e60831).

43

Lübbert M et al. Transient receptor potential channels encode volatile chemicals sensed by rat trigeminal ganglion neurons.
PLoS ONE, 2013 , 8 (e77998).